Beating earnings estimates typically has a positive impact on a company's stock price in the short term as it indicates better financial health and performance than expected by analysts. For ARS Pharmaceuticals, reporting a loss that is significantly less than expected could lead to increased investor confidence and a potential rise in stock price.